Observational study on quality of life, safety, and effectiveness of first‐line cetuximab plus chemotherapy in <i><scp>KRAS</scp></i> wild‐type metastatic colorectal cancer patients: the ObservEr Study

Carmine Pinto, Francesco Di Costanzo, Gerardo Rosati et al.|Cancer Medicine|2016

Cited by 26